Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible.

RMD Open · 2019 · PMC6667974 · PMID 31413869

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

did not reach statistical significancep=0.051so close (0.05 < p ≤ 0.1)

The incl group had a statistically significantly better response in HAQ (−0.8±0.7 vs excl −0.3±0.6, p=0.008) at 6 months, but this difference did not reach statistical significance at 18 months (−0.6±0.7 vs -0.3±0.6, p=0.051).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.